Royal Philips (PHG) announced the expansion of its partnership with Ibex Medical Analytics and a new release of Philips IntelliSite Pathology Solution to further accelerate the adoption of AI-enabled digital pathology to address the pressure pathologists face because of the global shortage of pathologists and the growing number of cancer patients. “Following the start of the partnership in 2021, Philips and Ibex can now offer even further interoperability of its solutions, aiming to enhance diagnostic workflows for clinicians and enabling better care for more people,” Philips said in a statement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
